More about

Myocardial Revascularization

News
July 06, 2023
3 min read
Save

Direct admission vs. interhospital transfer yields cost, outcomes benefits for non-STEMI

Adults with non-STEMI who went directly to a Netherlands intervention center had shorter hospital stays, less time to revascularization and lower costs compared with those who initially presented at a general center, researchers reported.

News
October 17, 2022
2 min read
Save

Mortality, recurrence low at 3 years in large SCAD cohort

In a large cohort of patients with spontaneous coronary artery dissection, the rates of mortality and recurrent spontaneous coronary artery dissection were low at 3 years, researchers reported.

News
June 26, 2020
2 min read
Save

In CABG, most outcomes similar in multiple vs. single arterial grafts

Among patients who underwent CABG, single arterial grafts and multiple arterial grafts were similar for all-cause mortality, CV mortality, MI and major bleeding, researchers reported.

News
May 14, 2020
2 min read
Save

Icosapent ethyl reduces revascularization events: REDUCE-IT REVASC

A prespecified analysis of the REDUCE-IT trial highlighted a reduction in first and total revascularization events with icosapent ethyl in patients with elevated triglycerides at high CV risk despite statin therapy.

News
December 20, 2019
1 min read
Save

Patients may not understand informed consent process before PCI

Discrepancies in understanding the informed consent process before PCI among patients and cardiologists showed that improvements are needed for patients to make an informed decision regarding revascularization, according to a study published in the European Journal of Cardiovascular Nursing.

News
October 03, 2019
2 min read
Save

CTO PCI similar to medical therapy in CV death, MI risk at 3 years: EURO-CTO

SAN FRANCISCO — At 3 years, among patients with a chronic total coronary occlusion, those who underwent CTO PCI had similar rates of CV death and MI compared with those on optimal medical therapy alone, according to the safety results of the EURO-CTO trial.

News
September 28, 2019
3 min read
Save

Benefit of nonculprit PCI for STEMI consistent regardless of timing: COMPLETE

SAN FRANCISCO — In patients with STEMI and multivessel disease, a strategy of nonculprit-lesion PCI with the goal of complete revascularization was superior to culprit-only revascularization for major CV events regardless of whether complete revascularization occurred during the index procedure, days later or weeks later, according to new insights from the COMPLETE trial.

News
September 27, 2019
3 min read
Save

Discordant iFR, FFR results do not confer poor outcomes

SAN FRANCISCO — Among patients who had invasive coronary angiography and physiological assessments for at least one artery with intermediate coronary stenosis, having a normal fractional flow reserve value but an abnormal instantaneous wave-free ratio value or vice versa did not raise risk for poor outcomes, researchers reported.

News
September 05, 2019
2 min read
Save

TRANSIENT: Timing of revascularization does not impact outcomes in transient STEMI

PARIS — In patients with transient STEMI, defined as those who present with STEMI but have their ST-segment elevation and symptoms completely resolve before revascularization, immediate revascularization led to similar outcomes as delayed revascularization, according to data from the TRANSIENT trial.